Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6368) 6368
Publication (326) 326
Book Review (48) 48
Magazine Article (27) 27
Book Chapter (22) 22
Book / eBook (7) 7
Conference Proceeding (3) 3
Web Resource (3) 3
Dissertation (2) 2
Newsletter (2) 2
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5650) 5650
male (3044) 3044
female (2634) 2634
adult (2308) 2308
middle aged (2183) 2183
clinical neurology (1919) 1919
aged (1421) 1421
neurosciences (1348) 1348
index medicus (1071) 1071
adolescent (919) 919
polyradiculoneuropathy - diagnosis (866) 866
polyradiculoneuropathy (853) 853
polyradiculoneuropathy - therapy (800) 800
polyradiculoneuropathy - etiology (754) 754
polyneuropathy (739) 739
polyradiculoneuropathy - physiopathology (739) 739
guillain-barre syndrome (737) 737
polyradiculoneuropathy - immunology (730) 730
child (696) 696
polyradiculoneuropathy - complications (627) 627
guillain-barre-syndrome (612) 612
neuropathy (537) 537
diagnosis, differential (529) 529
immunoglobulins, intravenous - therapeutic use (524) 524
polyradiculoneuropathy, chronic inflammatory demyelinating - diagnosis (460) 460
inflammatory demyelinating polyradiculoneuropathy (455) 455
cidp (444) 444
animals (437) 437
polyradiculoneuropathy, chronic inflammatory demyelinating - physiopathology (427) 427
guillain-barré syndrome (417) 417
chronic inflammatory demyelinating polyradiculoneuropathy (408) 408
child, preschool (404) 404
polyradiculoneuropathy - pathology (400) 400
acute disease (398) 398
neural conduction (384) 384
chronic inflammatory demyelinating polyneuropathy (376) 376
plasma exchange (376) 376
treatment outcome (368) 368
medicine, general & internal (361) 361
chronic disease (351) 351
neurology (349) 349
neural conduction - physiology (337) 337
polyradiculoneuropathy, chronic inflammatory demyelinating - drug therapy (334) 334
electromyography (332) 332
aged, 80 and over (324) 324
multifocal motor neuropathy (320) 320
intravenous immunoglobulin (319) 319
plasmapheresis (305) 305
retrospective studies (302) 302
plasma-exchange (299) 299
polyradiculoneuropathy, chronic inflammatory demyelinating - therapy (294) 294
prognosis (287) 287
diagnosis (272) 272
antibodies (269) 269
demyelination (266) 266
immunology (261) 261
psychiatry (261) 261
magnetic resonance imaging (259) 259
polyneuropathies (248) 248
peripheral neuropathy (247) 247
polyradiculoneuropathy, chronic inflammatory demyelinating - immunology (247) 247
biopsy (225) 225
immunoglobulins (225) 225
follow-up studies (222) 222
polyradiculoneuropathy - drug therapy (222) 222
polyradiculoneuropathy, chronic inflammatory demyelinating - pathology (222) 222
time factors (220) 220
double-blind (204) 204
recurrence (203) 203
demyelinating diseases - physiopathology (200) 200
inflammation (198) 198
peripheral nerves - physiopathology (196) 196
polyradiculoneuropathy, chronic inflammatory demyelinating - complications (195) 195
electrophysiology (192) 192
infant (190) 190
criteria (187) 187
neurologic examination (185) 185
inflammatory demyelinating polyneuropathy (183) 183
sural nerve - pathology (182) 182
syndrome (181) 181
gangliosides - immunology (178) 178
care and treatment (177) 177
polyradiculoneuropathy - epidemiology (176) 176
surgery (175) 175
conduction block (172) 172
multiple-sclerosis (157) 157
therapy (157) 157
electrodiagnosis (156) 156
polyradiculoneuropathy - cerebrospinal fluid (156) 156
peripheral nerves - pathology (154) 154
young adult (153) 153
research article (152) 152
polyradiculoneuropathy - microbiology (151) 151
demyelinating diseases - pathology (150) 150
autoantibodies - blood (144) 144
demyelinating diseases - diagnosis (144) 144
demyelinating diseases - therapy (142) 142
pediatrics (141) 141
enzyme-linked immunosorbent assay (139) 139
guillain-barre syndrome - diagnosis (138) 138
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4989) 4989
French (398) 398
Japanese (299) 299
Spanish (169) 169
German (166) 166
Russian (93) 93
Italian (61) 61
Chinese (45) 45
Polish (41) 41
Portuguese (34) 34
Dutch (17) 17
Czech (15) 15
Croatian (13) 13
Danish (11) 11
Norwegian (11) 11
Hungarian (10) 10
Swedish (10) 10
Serbian (9) 9
Turkish (9) 9
Korean (8) 8
Finnish (7) 7
Hebrew (6) 6
Romanian (3) 3
Slovak (2) 2
Bulgarian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Guillain-Barré syndrome
: from diagnosis to recovery
by Parry, Gareth J and Steinberg, Joel S
2007, American Academy of Neurology (AAN) quality of life guides, ISBN 1932603565, xiii, 264
Guillain-Barré syndrome
Book
Details down arrow
2. Full Text Advances in the diagnosis, pathogenesis and treatment of CIDP
by Dalakas, Marinos C and Medscape
Nature Reviews Neurology, ISSN 1759-4758, 09/2011, Volume 7, Issue 9, pp. 507 - 517
Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic autoimmune neuropathy. Despite clinical challenges in diagnosis-owing in... 
HIGH-DOSE CYCLOPHOSPHAMIDE | GUILLAIN-BARRE-SYNDROME | CLINICAL-RESEARCH STANDARDS | INFLAMMATORY-DEMYELINATING POLYNEUROPATHY | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | RANDOMIZED CONTROLLED-TRIAL | QUALITY-OF-LIFE | CHRONIC RELAPSING POLYNEUROPATHY | STEM-CELL TRANSPLANTATION | SURAL NERVE BIOPSIES | CLINICAL NEUROLOGY | Diagnosis, Differential | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - cerebrospinal fluid | Humans | Middle Aged | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - complications | Hematopoietic Stem Cell Transplantation | Adrenal Cortex Hormones - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - diagnosis | Disease Progression | Plasmapheresis | Electrodiagnosis | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - immunology | Immunoglobulins, Intravenous - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - therapy | Biopsy | Age of Onset | Adult | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - pathology | Immunoglobulins | Care and treatment | Polyneuropathies | Physiological aspects | Research | Diagnosis | T cells | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text CIDP diagnostic pitfalls and perception of treatment benefit
by Allen, Jeffrey A and Lewis, Richard A
Neurology, ISSN 0028-3878, 08/2015, Volume 85, Issue 6, pp. 498 - 504
OBJECTIVE:We aimed to explore the diagnosis and misdiagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) and to identify pitfalls that... 
CRITERIA | NERVE | PROGNOSIS | POLYRADICULONEUROPATHY | INFLAMMATORY DEMYELINATING POLYNEUROPATHY | ICE | PREVALENCE | PERIPHERAL NEUROPATHIES | CLINICAL NEUROLOGY | Diagnostic Errors - psychology | Humans | Middle Aged | Male | Neural Conduction - physiology | Treatment Outcome | Chi-Square Distribution | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - diagnosis | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - physiopathology | Young Adult | Electrodiagnosis | Immunoglobulins, Intravenous - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - therapy | Adult | Female | Aged | Retrospective Studies | Immunologic Factors - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - psychology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg
by Querol, Luis and Nogales-Gadea, Gisela and Rojas-Garcia, Ricardo and Diaz-Manera, Jordi and Pardo, Julio and Ortega-Moreno, Angel and Sedano, Maria Jose and Gallardo, Eduard and Berciano, Jose and Blesa, Rafael and Dalmau, Josep and Illa, Isabel
Neurology, ISSN 0028-3878, 03/2014, Volume 82, Issue 10, pp. 879 - 886
OBJECTIVE:To describe the frequency of antibodies against neurofascin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and the associated... 
TARGET | POLYRADICULONEUROPATHY | IMMUNOGLOBULIN | AXONAL DOMAINS | NEUROPATHIES | INFLAMMATORY DEMYELINATING POLYNEUROPATHY | CLINICAL NEUROLOGY | Severity of Illness Index | Humans | Middle Aged | Immunoglobulins, Intravenous - administration & dosage | Rats | Male | Treatment Outcome | Nerve Growth Factors - immunology | Cell Adhesion Molecules - immunology | Autoantibodies - biosynthesis | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - physiopathology | Immunoglobulins, Intravenous - pharmacology | Phenotype | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - immunology | Animals | Immunoglobulin G - immunology | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | HEK293 Cells | Adult | Female | Retrospective Studies | Tremor - drug therapy | Tremor - immunology | Drug Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition
by Vallat, Jean-Michel, MD and Sommer, Claudia, MD and Magy, Laurent, MD
Lancet Neurology, The, ISSN 1474-4422, 2010, Volume 9, Issue 4, pp. 402 - 412
Summary Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic neuropathy of supposed immune origin. Understanding of its... 
Neurology | HIGH-DOSE CYCLOPHOSPHAMIDE | GUILLAIN-BARRE-SYNDROME | TERM-FOLLOW-UP | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | MONOCLONAL GAMMOPATHY | RANDOMIZED CONTROLLED-TRIAL | IMMUNE-MEDIATED NEUROPATHIES | CLINICAL-FEATURES | SURAL NERVE BIOPSIES | STEM-CELL TRANSPLANTATION | CLINICAL NEUROLOGY | Diagnosis, Differential | Animals | Prognosis | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - epidemiology | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - therapy | Humans | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - diagnosis | Disease Progression | Health aspects | Immunoglobulins | Immunosuppressive agents | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Neurons and Cognition | Biochemistry, Molecular Biology | Genomics | Neurobiology | Life Sciences | Genetics | Molecular biology | Human genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP
by Nobile-Orazio, Eduardo and Cocito, Dario and Jann, Stefano and Uncini, Antonino and Messina, Paolo and Antonini, Giovanni and Fazio, Raffaella and Gallia, Francesca and Schenone, Angelo and Francia, Ada and Pareyson, Davide and Santoro, Lucio and Tamburin, Stefano and Cavaletti, Guido and Giannini, Fabio and Sabatelli, Mario and Beghi, Ettore and Paolasso, Ilaria and De Toni Franceschini, Luisa and Notturno, Francesca and Clemenzi, Alessandro and Bianchi, Francesca and Fiorina, Elisabetta and Pontecorvo, Simona and Piscosquito, Giuseppe and Manganelli, Fiore and Praitano, Maria Luigia and Piatti, Marialuisa and Torzini, Antonio and Luigetti, Marco and Macchia, Roberta and IMC Trial Grp and IMC Trial Group
Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, 07/2015, Volume 86, Issue 7, pp. 729 - 734
Background We reported that 6-month therapy with intravenous immunoglobulin (IVIg) was more frequently effective or tolerated than intravenous... 
SURGERY | POLYNEUROPATHY | DEXAMETHASONE | PSYCHIATRY | INTRAVENOUS METHYLPREDNISOLONE | IMMUNOGLOBULIN | RANDOMIZED CONTROLLED-TRIAL | INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | PREDNISOLONE | CLINICAL NEUROLOGY | PILOT | INTEROBSERVER AGREEMENT | INTERFERON BETA-1A | Recurrence | Methylprednisolone - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - epidemiology | Humans | Immunologic Factors - administration & dosage | Immunoglobulins, Intravenous - administration & dosage | Treatment Outcome | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - prevention & control | Immunoglobulins, Intravenous - therapeutic use | Time Factors | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Retrospective Studies | Immunologic Factors - therapeutic use | Methylprednisolone - administration & dosage | Treatment outcome | Care and treatment | Chronic inflammatory demyelinating polyradiculoneuropathy | Analysis | Dosage and administration | Methylprednisolone | Comparative analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia
by Miura, Yumako and Miura, Yumako and Devaux, Jérôme J and Devaux, Jérôme J and Fukami, Yuki and Fukami, Yuki and Manso, Constance and Manso, Constance and Belghazi, Maya and Belghazi, Maya and Wong, Anna H.iu Yi and Wong, Anna Hiu Yi and Yuki, Nobuhiro and Yuki, Nobuhiro and Fujimura, Harutoshi and Fukutake, Toshio and Iwanami, Hisatake and Kusaka, Hirohumi and Kuwabara, Satoshi and Okuma, Yasuyuki and Ueda, Mitsuharu and Yamamoto, Toru and CNTN-CIDP Study Grp and CNTN1-CIDP Study Group and for the CNTN1-CIDP Study Group
Brain, ISSN 0006-8950, 06/2015, Volume 138, Issue 6, pp. 1484 - 1491
A Spanish group recently reported that four patients with chronic inflammatory demyelinating polyneuropathy carrying IgG4 autoantibodies against contactin 1... 
myelin | chronic inflammatory demyelinating polyneuropathy | nodes of Ranvier | autoantibody | contactin 1 | PERIPHERAL-NERVE | GUILLAIN-BARRE | NODES | NEUROFASCIN | NEUROSCIENCES | CLINICAL NEUROLOGY | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - blood | Immunoglobulin G - blood | Autoantibodies - blood | Humans | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Case-Control Studies | Epitopes - immunology | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - immunology | Immunoglobulin G - immunology | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Aged, 80 and over | Ataxia - drug therapy | Contactin 1 - metabolism | Adult | Ataxia - blood | Female | Retrospective Studies | Ataxia - immunology | Cells, Cultured | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - complications | Biomarkers, Pharmacological - blood | Autoantibodies - immunology | Contactin 1 - immunology | Immunoglobulins, Intravenous - therapeutic use | Aged | Ataxia - complications | Ganglia, Spinal - metabolism | Life Sciences | Neurons and Cognition | Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision
by van den Bergh, Peter Y. K and Hadden, Robert D. M and Bouche, Pierre and Cornblath, David R and Hahn, Angelika and Illa, Isabel and Koski, Carol L and Leger, Jean-Marc and Nobile-Orazio, Eduardo and Pollard, John and Sommer, Claudia and van Doorn, Pieter A and van Schaik, Ivo N and EFNS & PNS and Joint Task Force of the EFNS and the PNS
Journal of the peripheral nervous system, ISSN 1085-9489, 2010, Volume 15, Issue 1, pp. 1 - 9
Recommendations: The Task Force agreed on Good Practice Points to define clinical and electrophysiological diagnostic criteria for CIDP with or without... 
Definition | Treatment | Diagnosis | Chronic inflammatory demyelinating polyradiculoneuropathy | Guidelines | treatment | POLYNEUROPATHY | chronic inflammatory demyelinating polyradiculoneuropathy | diagnosis | CIDP | NEUROSCIENCES | CLINICAL NEUROLOGY | RANDOMIZED CONTROLLED TRIAL | PLASMA-EXCHANGE | PREDNISONE | EFNS GUIDELINES | DOUBLE-BLIND | guidelines | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | definition | 10-PERCENT | INTERFERON BETA-1A | Immunoglobulins, Intravenous - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - therapy | Humans | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - complications | Plasma Exchange | Adrenal Cortex Hormones - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - diagnosis | Immunologic Factors - therapeutic use | Online health care information services | Task forces | Immunoglobulins | Immunosuppressive agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Rituximab treatment in patients with IVIg‐dependent immune polyneuropathy: A prospective pilot trial
by Gorson, Kenneth C and Natarajan, Neela and Ropper, Allan H and Weinstein, Robert
Muscle & Nerve, ISSN 0148-639X, 01/2007, Volume 35, Issue 1, pp. 66 - 69
We studied the effect of rituximab in allowing a reduction in dose of intravenous immune globulin (IVIg) in six patients with IVIg‐dependent, relapsing immune... 
chronic inflammatory demyelinating polyneuropathy | IVIg | intravenous immunoglobulins | immune neuropathy | CIDP | rituximab | Immune neuropathy | Rituximab | Intravenous immunoglobulins | Chronic inflammatory demyelinating polyneuropathy | MULTIFOCAL MOTOR NEUROPATHY | GAMMOPATHY | DISEASES | INTRAVENOUS IMMUNOGLOBULIN | IVlg | NEUROSCIENCES | Prospective Studies | Humans | Endpoint Determination - methods | Motor Neuron Disease - immunology | Immunoglobulins, Intravenous - administration & dosage | Sjogren's Syndrome - immunology | Peripheral Nerves - immunology | Peripheral Nerves - drug effects | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - physiopathology | Dose-Response Relationship, Drug | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - immunology | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Motor Neuron Disease - drug therapy | Motor Neuron Disease - physiopathology | Antibodies, Monoclonal, Murine-Derived | Sjogren's Syndrome - drug therapy | Immunologic Factors - administration & dosage | Sjogren's Syndrome - physiopathology | Treatment Outcome | Peripheral Nerves - physiopathology | Drug Synergism | Myelin-Associated Glycoprotein - immunology | Pilot Projects | Polyradiculoneuropathy - physiopathology | Antibodies, Monoclonal - administration & dosage | Polyradiculoneuropathy - immunology | Polyradiculoneuropathy - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy
by Delmont, Emilien and Manso, Constance and Querol, Luis and Cortese, Andrea and Berardinelli, Angela and Lozza, Alessandro and Belghazi, Maya and Malissart, Pauline and Labauge, Pierre and Taieb, Guillaume and Yuki, Nobuhiro and Illa, Isabel and Attarian, Shahram and Devaux, Jérôme J
Brain, ISSN 0006-8950, 07/2017, Volume 140, Issue 7, pp. 1851 - 1858
Chronic inflammatory demyelination polyneuropathy is a heterogeneous and treatable immune-mediated disorder that lacks biomarkers to support diagnosis. Recent... 
myelin | paranode | IVIg | CIDP | Guillain-Barré syndrome | TARGET | Guillain-Barre syndrome | NEUROSCIENCES | IGG4 ANTIBODIES | CLINICAL NEUROLOGY | MEMBRANOUS GLOMERULONEPHRITIS | POLYRADICULONEUROPATHY | NEUROPATHIES | CONDUCTION | PROTEINS | AXONAL INJURY | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - blood | Ranvier's Nodes - immunology | Autoantibodies - blood | Humans | Middle Aged | Child, Preschool | Male | Cell Adhesion Molecules - immunology | Adrenal Cortex Hormones - therapeutic use | Case-Control Studies | Young Adult | Rituximab - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - immunology | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Aged, 80 and over | Adult | Female | Child | Neural Conduction - physiology | Nerve Growth Factors - immunology | Autoantibodies - immunology | Immunoglobulins, Intravenous - therapeutic use | Adolescent | Aged | Protein Isoforms - immunology | Life Sciences | Neurons and Cognition
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy
by Nevo, Yoram and Ben-Zeev, Bruria and Tabib, Adi and Straussberg, Rachel and Anikster, Yair and Shorer, Zamir and Fattal-Valevski, Aviva and Ta-Shma, Asaf and Aharoni, Sharon and Rabie, Malcolm and Zenvirt, Shamir and Goldshmidt, Hanoch and Fellig, Yakov and Shaag, Avraham and Mevorach, Dror and Elpeleg, Orly
Blood, ISSN 0006-4971, 01/2013, Volume 121, Issue 1, pp. 129 - 135
CD59 deficiency is a common finding in RBCs and WBCs in patients with chronic hemolysis suffering from paroxysmal nocturnal hemoglobinuria in which the... 
MEMBRANE ATTACK | COMPLEMENT | ACTIVATION | ERYTHROCYTES | GENE | TERM-FOLLOW-UP | INFLAMMATORY DEMYELINATING POLYNEUROPATHY | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | HEMATOLOGY | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - blood | Hemoglobinuria - ethnology | Hemoglobinuria - genetics | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - cerebrospinal fluid | Humans | Child, Preschool | Molecular Sequence Data | Infant | Male | Anemia, Hemolytic - genetics | Mutation, Missense | Libya - ethnology | Jews - genetics | Membrane Proteins - analysis | Founder Effect | Morocco - ethnology | Anemia, Hemolytic - cerebrospinal fluid | Female | Anemia, Hemolytic - ethnology | Amino Acid Sequence | CD59 Antigens - genetics | Protein Transport | Hemoglobinuria - cerebrospinal fluid | Point Mutation | Pedigree | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - ethnology | Age of Onset | Hemoglobinuria - blood | CD59 Antigens - metabolism | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - genetics | Anemia, Hemolytic - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Incidence and prevalence of CIDP and the association of diabetes mellitus
by Laughlin, R.S and Dyck, P.J and Melton III, L.J and Leibson, C and Ransom, J and Dyck, P.J.B
Neurology, ISSN 0028-3878, 2009, Volume 73, Issue 1, pp. 39 - 45
Background: The reported prevalence of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) varies greatly, from 1.9 to 7.7 per 100,000. CIDP is... 
RATES | GUILLAIN-BARRE-SYNDROME | POLYRADICULONEUROPATHY | NEUROPATHIES | INFLAMMATORY DEMYELINATING POLYNEUROPATHY | ELECTRODIAGNOSTIC CRITERIA | CLINICAL NEUROLOGY | Prevalence | Humans | Middle Aged | Child, Preschool | Male | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - diagnosis | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - physiopathology | Incidence | Young Adult | Electrodiagnosis | Aged, 80 and over | Diabetes Complications - epidemiology | Adult | Female | Peripheral Nerves - metabolism | Child | Diabetes Complications - physiopathology | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - epidemiology | Comorbidity | Diabetes Complications - metabolism | Risk Factors | Diabetes Mellitus - metabolism | Neural Conduction - physiology | Minnesota | Peripheral Nerves - pathology | Peripheral Nerves - physiopathology | Diabetes Mellitus - physiopathology | Diabetes Mellitus - epidemiology | Adolescent | Aged | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Different electrophysiological profiles and treatment response in ‘typical’ and ‘atypical’ chronic inflammatory demyelinating polyneuropathy
by Kuwabara, Satoshi and Isose, Sagiri and Mori, Masahiro and Mitsuma, Satsuki and Sawai, Setsu and Beppu, Minako and Sekiguchi, Yukari and Misawa, Sonoko
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 10/2015, Volume 86, Issue 10, pp. 1054 - 1059
BackgroundChronic inflammatory demyelinating polyneuropathy (CIDP) is currently classified into ‘typical’ CIDP and ‘atypical’ subtypes such as multifocal... 
MULTIFOCAL MOTOR NEUROPATHY | SURGERY | DIAGNOSIS | PROGNOSIS | PSYCHIATRY | GUILLAIN-BARRE-SYNDROME | POLYRADICULONEUROPATHY | FOLLOW-UP | PATTERNS | CLINICAL NEUROLOGY | Prognosis | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Neural Conduction | Treatment Outcome | Adrenal Cortex Hormones - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - physiopathology | Plasmapheresis | Sural Nerve - physiopathology | Immunoglobulins, Intravenous - therapeutic use | Polyradiculoneuropathy - physiopathology | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - therapy | Adult | Female
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights